22nd Century Cash Flow from Investing Activities 2011-2023 | XXII
22nd Century cash flow from investing activities from 2011 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
22nd Century Annual Cash Flow Investing
(Millions of US $) |
| 2023 |
$17 |
| 2022 |
$23 |
| 2021 |
$-28 |
| 2020 |
$16 |
| 2019 |
$5 |
| 2018 |
$15 |
| 2017 |
$-61 |
| 2016 |
$-1 |
| 2015 |
$-0 |
| 2014 |
$-3 |
| 2013 |
$-4 |
| 2012 |
$-0 |
| 2011 |
$-1 |
| 2010 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.012B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
